Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents

Clinical pharmacology and therapeutics

Volumn 96, Issue 4, 2014, Pages 429-437

  Gonzalez, D ^a   Melloni, C ^a   Yogev, R ^a   Poindexter, B B ^a   Mendley, S R ^a   Delmore, P ^a   Sullivan, J E ^a   Autmizguine, J ^a   Lewandowski, A ^a   Harper, B ^a   Watt, K M ^a   Lewis, K C ^a   Capparelli, E V ^a   Benjamin, D K ^a   Cohen Wolkowiez, M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN;

ADOLESCENT; BIOLOGICAL MODEL; CHILD; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PREMATURITY; PRESCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MODELS, BIOLOGICAL;

EID: 84921670591     PISSN: None     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.134     Document Type: Article

References (0)